FDA Approved: DEXTROAMPHETAMINE — Supplemental Application (Cranbury Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved Cranbury Pharmaceuticals' supplemental application for dextroamphetamine (generic) under ANDA 203644, enabling the generic product to be market…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Narcolepsy

Drugs mentioned

• Dextroamphetamine (Dextroamphetamine)

Snippet

SUPPL AP for DEXTROAMPHETAMINE (DEXTROAMPHETAMINE)